Evidence map›Paper›PMID 37538494›Full record

ArticleResearch and practice in thrombosis and haemostasis2023

Illustrated State-of-the-Art Capsules of the ISTH 2023 Congress.

Susan R Kahn, Donald M Arnold, Caterina Casari, Karl C Desch, Katrien M J Devreese, Emmanuel J Favaloro, Florian Gaertner, Samantha C Gouw, Paolo Gresele, Arjan W Griffioen and 17 more

Abstract read
In one paragraph

Article in Research and practice in thrombosis and haemostasis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Cancer and arterial thrombosis: therapeutic options.Research and practice in thrombosis and haemostasis · 2024
    Article
  2. Hello and goodbye Research and Practice in Thrombosis and Haemostasis.Research and practice in thrombosis and haemostasis · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Susan R KahnMedicine, Sir Mortimer B Davis Jewish General Hospital, McGill University, 3755 Cote Ste Catherine, Montreal, Quebec.
Donald M ArnoldDepartment of Medicine, McMaster University, Hamilton, ON, Canada.
Caterina CasariUniversité Paris-Saclay, INSERM, Hémostase inflammation thrombose HITH U1176, 94276, Le Kremlin-Bicêtre, France.
Karl C DeschCell and Molecular Biology Program, University of Michigan, Ann Arbor, USA.
Katrien M J DevreeseCoagulation Laboratory, Department of Laboratory Medicine, Ghent University Hospital, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.
Emmanuel J FavaloroHaematology, Sydney Centres for Thrombosis and Haemostasis, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, NSW Australia.
Florian GaertnerTechnische Universität München (TUM), Ismaninger Straße 22, München, Bayern 81675, Germany.
Samantha C GouwAmsterdam UMC location University of Amsterdam, Department of Pediatric Hematology, Meibergdreef 9, Amsterdam, The Netherlands.
Paolo GreseleUniversity of Perugia, Department of Medicine and Surgery, Head Section of Internal and Cardiovascular Medicine.
Arjan W GriffioenAngiogenesis Laboratory, Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Lukas HegerDepartment of Pediatrics, Harvard Medical School, Boston, MA 02115, USA; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Departement of Cardiology and Angiology, University Hospital Freiburg Bad Krozingen, 79106 Freiburg, Germany.
R Manjunatha KiniNational University of Singapore, Singapore.
Shrey KohliInstitute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, Universitätsklinikum Leipzig, Leipzig University, 04103 Leipzig, Germany.
Avi LeaderInstitute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Ton LismanSurgical Research Laboratory and Section of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Marie LordkipanidzéFaculty of pharmacy, University of Montreal.
Eric MullinsDivision of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Helen Chioma OkoyeCollege of Medicine, University of Nigeria, Ituku Ozalla campus, Enugu Nigeria.
Rachel P RosovskyMassachusetts General Hospital.
Isabelle I Salles-CrawleySt George's University of London.
Rita SelbyDepartments of Laboratory Medicine & Pathobiology and Department of Medicine, University of Toronto.
Michelle SholzbergSt. Michael's Hospital, University of Toronto.
David StegnerJulius-Maximilians-Universität Würzburg.
Francesco VioliDepartment of Clinical, Internal Medicine, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
Angela C WeyandDepartment of Pediatrics, University of Michigan Medical School.
Suzan WilliamsHospital for Sick Children, University of Toronto.
Ze ZhengMedical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.

Funding

The Molecular Genetics of Venous Thromboembolic DiseaseR01HL141399 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DESCH, KARL C · 2018 to 2022
$1.9M
NHLBI NIH HHS R01 HL141399
6 · The paper itself

Abstract

This year's Congress of the International Society of Thrombosis and Haemostasis (ISTH) took place in person in Montréal, Canada, from June 24-28, 2023. The conference, held annually, highlighted cutting-edge advances in basic, translational, population and clinical sciences relevant to the Society. As for all ISTH congresses, we offered a special, congress-specific scientific theme; this year, the special theme was immunothrombosis. Certainly, over the last few years, COVID-19 infection and its related thrombotic and other complications have renewed interest in the concepts of thromboinflammation and immunothrombosis; namely, the relationship between inflammation, infection and clotting. Other main scientific themes of the Congress included Arterial Thromboembolism, Coagulation and Natural Anticoagulants, Diagnostics and Omics, Fibrinolysis and Proteolysis, Hemophilia and Rare Bleeding Disorders, Hemostatic System in Cancer, Inflammation and Immunity, Pediatrics, Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies, Platelets and Megakaryocytes, Vascular Biology, Venous Thromboembolism and Women's Health. Among other sessions, the program included 28 State-of-the-Art (SOA) sessions with a total of 84 talks given by internationally recognized leaders in the field. SOA speakers were invited to prepare brief illustrated reviews of their talks that were peer reviewed and are included in this article. These illustrated capsules highlight the major scientific advances with potential to impact clinical practice. Readers are invited to take advantage of the excellent educational resource provided by these illustrated capsules. They are also encouraged to use the image in social media to draw attention to the high quality and impact of the science presented at the Congress.

Identifiers

PMID37538494
PMCPMC10394567

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.